| Literature DB >> 35626244 |
Friederike Schömig1, Zhao Li1, Luis Becker1, Tu-Lan Vu-Han1, Matthias Pumberger1, Torsten Diekhoff2.
Abstract
Gas in the intervertebral disc is mainly associated with degenerative disc diseases and experts generally assume that it is unlikely in spinal infection. However, large-scale studies supporting this notion are lacking, which is why our study's aim was to analyze the prevalence of and factors associated with the occurrence of gas in patients with spontaneous spondylodiscitis. Patients presenting with spontaneous spondylodiscitis from 2006 to 2020 were included retrospectively. Exclusion criteria were previous interventions in the same spinal segment and missing imaging data. Clinical data were retrieved from electronic medical reports. Computed tomography (CT) scans were evaluated for the presence of intervertebral gas. Causative pathogens were identified from CT-guided biopsy, open biopsy, intraoperative tissue samples, and/or blood cultures. 135 patients with a mean age of 66.0 ± 13.7 years were included. In 93 patients (68.9%), a causative pathogen was found. Intervertebral gas was found in 31 patients (23.0%) in total and in 19 patients (20.4%) with positive microbiology. Patients with gas presented with significantly higher body temperatures (37.2 ± 1.1 vs. 36.8 ± 0.7 °C, p = 0.044) and CRP levels (134.2 ± 127.1 vs. 89.8 ± 97.3 mg/L, p = 0.040) on admission. As a considerable number of patients with spondylodiscitis showed intervertebral gas formation, the detection of intervertebral gas is not suited to ruling out spondylodiscitis but must be interpreted in the context of other imaging and clinical findings, especially in elderly patients.Entities:
Keywords: diagnosis; infection; spine surgery; spondylodiscitis; vacuum phenomenon
Year: 2022 PMID: 35626244 PMCID: PMC9139794 DOI: 10.3390/diagnostics12051089
Source DB: PubMed Journal: Diagnostics (Basel) ISSN: 2075-4418
Figure 1Flow chart of patient inclusion.
Methods performed for pathogen identification in the two treatment groups.
| Conservative Treatment ( | Surgical Treatment ( | |
|---|---|---|
|
| 29 (82.9%) | 18 (18.0%) |
|
| 2 (5.7%) | 44 (44.0%) |
|
| - | 88 (88.0%) |
Figure 2Imaging examples of two patients with confirmed spondylodiscitis. (A). Sagittal (A1) and transverse (A2) CT images showing gas within the disc (arrowhead), within the vertebra and within an epidural abscess (arrows) of a 50-year-old patient with urosepsis and spondylodiscitis L5/S1. Blood cultures and intraoperative tissue samples revealed Escherichia coli as the causative pathogen. (B). Sagittal (B1) and coronal (B2) CT images of intervertebral gas (B1, arrowheads) within three discs and gas (B2, arrowheads) within a psoas abscess (B2, arrows) of a 75-year-old patient with spondylodiscitis L1-3. Blood cultures and biopsy samples revealed Streptococcus pyogenes as the causative pathogen.
Patient characteristics of gas-positive and gas-negative patient groups. * indicates statistically significant results. BMI, body mass index; CCI, Charlson Comorbidity Index; IV, intravenous; HIV, human immunodeficiency virus; VAS, visual analog scale; CRP, C-reactive protein; WBC, white blood cell count; Hb, hemoglobin.
| Gas-Positive ( | Gas-Negative ( | ||
|---|---|---|---|
|
| 71.9 ± 10.8 | 64.0 ± 13.9 | 0.004 * |
|
| 14:17 | 47:57 | 0.998 |
|
| 27.6 ± 6.1 | 26.4 ± 6.2 | 0.361 |
|
| 3.9 ± 2.9 | 2.7 ± 2.8 | 0.044 * |
|
| |||
| Smoking | 7/31 (22.6%) | 21/94 (22.3%) | 0.978 |
| Diabetes | 9/31 (29.0%) | 22/104 (21.2%) | 0.360 |
| Cancer | 15/31 (48.4%) | 28/104 (26.9%) | 0.024 * |
| IV drugs | 0/31 (0%) | 1/104 (1.0%) | 1.000 |
| HIV | 1/31 (3.2%) | 1/104 (1.0%) | 0.408 |
|
| |||
| Body temperature (°C) | 37.2 ± 1.1 | 36.8 ± 0.7 | 0.044 * |
| Fever | 6/29 (20.7%) | 7/98 (7.1%) | 0.035 * |
| Back pain at rest (VAS) | 4.0 ± 2.6 | 3.9 ± 2.7 | 0.950 |
| Back pain moving (VAS) | 5.5 ± 2.7 | 5.7 ± 2.7 | 0.652 |
|
| 0.066 | ||
| Cervical | 1/31 (3.2%) | 6/104 (5.8%) | |
| Thoracic | 4/31 (12.9%) | 33/104 (31.7%) | |
| Lumbar | 25/31 (80.6%) | 56/104 (53.8%) | |
| Disseminated | 1/31 (3.2%) | 9/104 (8.7%) | |
|
| |||
| CRP (mg/L) | 134.2 ± 127.1 | 89.8 ± 97.3 | 0.040 * |
| WBC (/nL) | 11.7 ± 6.2 | 10.2 ± 5.7 | 0.209 |
| Hb (g/dL) | 11.7 ± 2.0 | 11.3 ± 1.7 | 0.241 |
|
| 19/31 (61.3%) | 74/104 (71.2%) | 0.298 |
|
| 0.986 | ||
| Conservative | 8/31 (25.8%) | 27/104 (26.7%) | |
| Surgical | 23/31 (74.2%) | 77/104 (73.3%) | |
|
| 25.4 ± 17.6 | 22.1 ± 17.8 | 0.369 |
Pathogen spectra found in gas-positive and gas-negative patient groups. * indicates statistically significant results.
| Gas-Positive ( | Gas-Negative ( | ||
|---|---|---|---|
|
| 4/19 (21.1%) | 24/74 (32.4%) | 0.410 |
|
| 7/19 (36.8%) | 22/74 (29.7%) | 0.551 |
|
| 2/19 (10.5%) | 10/74 (13.5%) | 0.729 |
|
| 3/19 (15.8%) | 6/74 (8.1%) | 0.382 |
|
| 3/19 (15.8%) | 1/74 (1.4%) | 0.026 * |
|
| 3/19 (15.8%) | 6/74 (8.1%) | 0.382 |
|
| 0/19 (0%) | 3/74 (4.1%) | 0.372 |
|
| 3/19 (15.8%) | 6/74 (8.1%) | 0.382 |